BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Summary

This study is a single-arm, multicenter clinical trial of dose escalation and dose expansion.

Timeline

Start

2025-10-10

Primary completion

2028-10-09

Completion

2028-12-09

Outcome

Outcome not reported

Stopped (Business): “Due to corporate strategic adjustment.”

Drugs

Indications